Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 67 (RPL7AP67)

Target
RPL7AP67
Molecular classification
Pseudogene
01

Overview

RPL7AP67 is a pseudogene related to the gene for ribosomal protein L7a. Pseudogenes are noncoding DNA segments derived from functional genes, often through duplication or retrotransposition, that generally do not encode functional proteins[4][5]. While most pseudogenes are thought to be transcriptionally inactive, recent research shows that some pseudogenes can produce regulatory RNA molecules that modulate their parental gene or other genes through transcript competition, miRNA decoy action, or formation of double-stranded RNA[2][6]. There is currently no evidence that RPL7AP67 serves as a drug target, clinical biomarker, or has direct relevance to human disease.

Other names
RPL7A_29_1595RPL7AP67
02

Mechanism of action

Not applicable for drug targeting; pseudogenes may act as endogenous regulators by RNA-based mechanisms if transcribed[2][6].

03

Biological functions

As a pseudogene, direct biological functions are not defined; however, pseudogenes may regulate expression of their parental genes by acting as microRNA decoys, generating siRNAs, or modulating gene regulation through antisense transcripts and competing for RNA-binding proteins[2][6].
04

Disease associations

No specific disease associations for RPL7AP67 itself, but some pseudogenes have regulatory effects in cancer and other diseases through parental gene modulation[2][6].
05

Safety considerations

None known; as a pseudogene, it is rarely associated directly with safety concerns or therapeutic targeting.
06

Interacting drugs

None known for RPL7AP67[4][5].
07

Biomarkers

No evidence for RPL7AP67 as a clinical biomarker[4][5].

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 67 (RPL7AP67).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 67 (RPL7AP67).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call